These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4050634)

  • 21. Cinoxacin (Cinobac) for urinary tract infections.
    Drug Ther Bull; 1980 Jun; 18(12):47-8. PubMed ID: 6993169
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of postoperative urinary infections in obstetrics and gynecology with cinoxacin].
    Bardi M; Manzoni A
    Clin Ter; 1988 Nov; 127(3):185-8. PubMed ID: 2976355
    [No Abstract]   [Full Text] [Related]  

  • 23. Cinoxacin therapy for urinary tract infections: therapeutic safety and efficacy.
    Cox CE; Simmons JR
    South Med J; 1982 May; 75(5):549-50. PubMed ID: 7043747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cinobar, a new antimicrobial agent for the treatment of urinary infections].
    Chantrie M
    Acta Urol Belg; 1980 Apr; 48(2):293-7. PubMed ID: 7006345
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparative evaluation of cinoxacin, cotrimoxazole and pipemidic acid in recurrent infections of the lower urinary tract in long-term therapy].
    Aimè G; Governa M; Polledro P
    Minerva Urol Nefrol; 1987; 39(2):129-34. PubMed ID: 3498226
    [No Abstract]   [Full Text] [Related]  

  • 26. [A comparison of cinoxacin and nalidixic acid in the treatment of chronic urinary tract infections].
    Briedigkeit H; Schimmelpfennig R; Buder R; Precht K; Dröseler H
    Infection; 1982; 10(4):219-22. PubMed ID: 7129643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparative drug study of lower urinary tract infections in elderly patients.
    Lindan R
    Urology; 1981 May; 17(5):502-4. PubMed ID: 7233673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical experience with cefmenoxime (CMX) in complicated urinary tract infections].
    Minami Y; Kanda S; Matsuo R; Sakai H; Kamemoto H; Hisamatsu A; Maruta N; Johdai A; Shimomae H; Watanabe Y
    Hinyokika Kiyo; 1985 Jun; 31(6):1077-84. PubMed ID: 3864365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical study of cinoxacin in acute simple cystitis].
    Inaba T; Watanabe H; Ohe H
    Hinyokika Kiyo; 1986 Feb; 32(2):293-6. PubMed ID: 3524157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative clinical study of the antibacterial activity of cinoxacin and norfloxacin in urinary tract infections].
    Pennisi M; Viscusi G; Salanitri G; Cammarata E; Gazzo G
    Minerva Urol Nefrol; 1987; 39(1):51-6. PubMed ID: 3616862
    [No Abstract]   [Full Text] [Related]  

  • 31. A clinical comparison of cinoxacin and nalidixic acid in the treatment of urinary tract infection.
    Bucy JG
    J Urol; 1981 Jun; 125(6):822-4. PubMed ID: 7017171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical experience of norfloxacin in urinary tract infection].
    Banya Y; Funaki H; Takagane H; Tanji S; Abe T; Aoki H; Kubo T; Ohori T
    Hinyokika Kiyo; 1985 Aug; 31(8):1501-17. PubMed ID: 4083210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical experience of enoxacin complicated urinary tract infection].
    Togashi M; Arakawa M; Tsubo S; Sakashita S; Maru A; Koyanagi T; Nakanishi S; Kakizaki H; Minami S; Kanagawa K
    Hinyokika Kiyo; 1988 Dec; 34(12):2233-6. PubMed ID: 3071131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical evaluation of Claforan (CTX) in aged patients with chronic complicated urinary tract infections].
    Washida H; Tsugaya M; Hirao N; Hachisuka Y
    Hinyokika Kiyo; 1984 Jan; 30(1):121-9. PubMed ID: 6328960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cinoxacin. A review of its pharmacological properties and therapeutic efficacy in the treatment of urinary tract infections.
    Sisca TS; Heel RC; Romankiewicz JA
    Drugs; 1983 Jun; 25(6):544-69. PubMed ID: 6347618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical study of cefotetan in complicated urinary tract infections].
    Suzuki T; Soma H; Tazawa H; Hamada W; Sugihara K; Fukushi M; Eba H
    Hinyokika Kiyo; 1987 Nov; 33(11):1917-20. PubMed ID: 3481955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful use of reduced dosage of cinoxacin in the treatment of recurrent urinary infection.
    Brumfitt W; Smith GW; Hamilton-Miller JM; Bax R
    J Antimicrob Chemother; 1985 Dec; 16(6):781-8. PubMed ID: 4093347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cinoxacin for treatment and prevention of recurrent urinary tract infection.
    Landes RR
    Urology; 1981 May; 17(5):505-10. PubMed ID: 7015670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical evaluation of ceftizoxime in the treatment of complicated urinary tract infections].
    Takaha M; Ichikawa Y; Sagawa S; Sonoda T; Nakamura T; Kotake T; Miki T; Yano H; Itatani H; Shin T
    Hinyokika Kiyo; 1984 Oct; 30(10):1519-29. PubMed ID: 6098179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylactic efficacy of cinoxacin in recurrent urinary tract infection: biologic effects on the vaginal and fecal flora.
    Schaeffer AJ; Jones JM; Flynn SS
    J Urol; 1982 Jun; 127(6):1128-31. PubMed ID: 7087019
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.